Medtronic's $200 million acquisition of Cardiocom brings Medtronic downstream into a rapidly strengthening link in the value chain: Wireless patient monitoring. Earlier this month, the Food and Drug Administration (FDA) released guidance on the the employment of radio frequency wireless technology in medical devices, giving investors and developers some confidence that the regulator will welcome their inventions. The acquisition allows the device maker to become a solutions provider instead of a...
Medtronic's $200 million acquisition of Cardiocom brings Medtronic downstream into a rapidly strengthening link in the value chain: Wireless patient monitoring. Earlier this month, the Food and Drug Administration (FDA) released guidance on the the employment of radio frequency wireless technology in medical devices, giving investors and developers some confidence that the regulator will welcome their inventions. The acquisition allows the device maker to become a solutions provider instead of a...
Share this Article
Recommended